Summary
“Two-route chemotherapy” (TRC) using cis-diamminedichloroplatinum(II) (DDP) and its antidote, sodium thiosulfate (STS), combined with the angiotensin II (AT-II)-induced hypertension method was evaluated for its efficacy against peritoneally disseminated tumors in rats. A bolus i.p. injection of DDP (15 mg/kg) was given 1 min after the initiation of an AT-II (16.5 μg/kg) i.v. infusion lasting 11 min. Immediately after the termination of the AT-II infusion, 1,580 mg/kg STS was injected i.v. over a further 5 min. This modified TRC significantly improved the antitumor effect, evaluated by survival (increase in life span, 273%), compared with that achieved with other treatments, as follows: 15 mg/kg DDP i.p. and the concomitant i.v. infusion of 1,580 mg/kg STS (conventional TRC), 153% increase in life span; 5 mg/kg DDP i.p. with or without AT-II i.v. (167% and 107% increases in life span, respectively). As an index of nephrotoxicity, blood urea nitrogen (BUN) levels seen after modified TRC (21.1 mg/dl) were as low as those observed after conventional TRC (19.1 mg/dl), despite the postadministration of STS, and were much lower than those seen after DDP alone or DDP plus AT-II (35.6 and 35.7 mg/dl, respectively). Further evaluation of the effectiveness of modified TRC using various doses of DDP gave similar results. The feasibility of the administration of STS 10 min after DDP treatment was explained by the significant inhibition of DDP delivery to the kidney during the AT-II-induced hypertension. Thus, TRC combined with AT-II has a superior therapeutic effect against peritonitis carcinomatosa induced in rats.
Similar content being viewed by others
References
Aamdal S, Fodstad Ø, Pihl A (1988) Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum(II) in mice bearing murine and human tumors. Cancer Chemother Pharmacol 21: 129
Baba T, Nishikawa K (1980) Effective combination of anticancer drug with its antidote for chemotherapy of hepatic metastasis. Gann 71: 157
Bannister SJ, Chang Y, Sternson LA, Repta AJ (1978) Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II). Clin Chem 24: 877
Casper ES, Kelsen DP, Alcock NW, Lewis JL Jr (1983) I.p. cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the i.v. route. Cancer Treat Rep 67: 235
Chen KK, Rose CL (1952) Nitrite and thiosulfate therapy in cyanide poisoning. J Am Med Assoc 149: 113
Dedrick RL, Myers CE, Bungary PM, DeVita VT (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62: 1
Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13: 156
Fukushima S, Hirose M, Tsuda H, Shirai T, Hirao K, Arai M, Ito N (1976) Histological classification of urinary bladder cancers in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Gann 67: 81
Hatae M, Tezuka H, Ushiki N, Ezono Y, Igyuin H, Terahara M, Hokanishi H (1984) Intraperitoneal and intrapleural two channel chemotherapy by cis-dichlorodiammineplatinum(II) (DDP)-sodium thiosulfate (STS) to ovarian cancer and peritonitis carcinomatosa. Jpn J Cancer Chemother 11: 433
Hori K, Suzuki M, Abe I, Saito S, Sato H (1985) Increase in tumor vascular area due to increased blood flow by angiotensin II in rats. J Natl Cancer Inst 74: 453
Howell SB, Taetle R (1980) Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64: 611
Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845
Howell SB, Pfeifle CE, Wung WE, Olshen RA (1983) Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 43: 1426
Ishizawa M, Taniguchi S, Baba T (1981) Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum(II) in bacteria and mice. Jpn J Pharmacol 31: 883
Iwamoto Y (1985) “Two-route chemotherapy” using high-dose intra-arterial cis-diamminedichloroplatinum(II) and systemic sodium thiosulfate, its antidote, for rat limb tumor. J Jpn Orthop Assoc 59: 865
Iwamoto Y, Aoki K, Kawano T, Baba T (1984) Upper hemibody infusion of cis-diamminedichloroplatinum(II) followed by systemic antidote, sodium thiosulfate, for lung metastasis in rats. Clin Exp Metastasis 2: 261
Iwamoto Y, Kawano T, Uozumi J, Aoki K, Baba T (1984) “Two-route chemotherapy” using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice. Cancer Treat Rep 68: 1367
Iwamoto Y, Kawano T, Ishizawa M, Aoki K, Kuroiwa T, Baba T (1985) Inactivation of cis-diamminedichloroplatinum(II) in blood and protection of its toxicity by sodium thiosulfate in rabbits. Cancer Chemother Pharmacol 15: 228
Koba F, Tsuji H, Abe R, Asoh T, Miyazaki S, Shirasaka C, Takeuchi Y, Arinaga S, Wada T, Uchida I, Akiyoshi T, Baba T (1983) Two-route infusion chemotherapy for primary and metastatic liver cancer. Jpn J Cancer Chemother 10: 1684
Konishi T, Kitamura M, Suzuki T, Mori T, Awane Y, Kosaki G (1985) Intra-arterial infusion therapy with angiotensin II for gastric carcinoma. Jpn J Cancer Chemother 12: 1905
Krakoff IH (1979) Nephrotoxicity of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63: 1523
Kuroiwa T, Aoki K, Taniguchi S, Hasuda K, Baba T (1987) Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor. Cancer Res 47: 3618
Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 95: 99
Markman M (1986) Intracavitary chemotherapy. Curr Probl Cancer 10: 402
Markman M, Cleary S, Pfeifle CE, Howell SB (1985) High-dose intracavitary cisplatin with intravenous thiosulfate. Cancer 56: 2364
Newman EV, Gilman A, Philips FS (1946) The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79: 229
Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M (1987) Intraperitoneal high-dose cisplatin chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis. Jpn J Cancer Chemother 14: 1025
Noguchi S, Miyauchi K, Nishizawa Y, Sasaki Y, Imaoka S, Iwanaga T, Koyama H, Terasawa T (1988) Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer 62: 467
Nojiri O, Nakamura M, Tanaka Y, Banno T (1988) Two-route chemotherapy by CDDP and STS against liver metastasis of gastrointestinal adenocarcinoma. Jpn J Cancer Chemother 15: 47
Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Young RC (1979) Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39: 3209
Pretorius RG, Petrilli ES, Kean C, Ford LC, Hoeschele JD, Lagasse LD (1981) Comparison of the iv and ip routes of administration of cisplatin in dogs. Cancer Treat Rep 65: 1055
Riabchikov DI (1941) The reactions with thiosulfate as a method for determining the nature of isomerism of platinum complex compounds. C R (Dokl) Acad Sci URSS 32: 344
Rosivall L, Navar LG (1983) Effects of renal hemodynamics of intra-arterial infusions of angiotensins I and II. Am J Physiol 245 (Renal Fluid Electrolyte Physiol 14): F181
Sagiyama K, Uozumi J, Aoki K, Baba T (1983) Efficacy of “two-route chemotherapy” using intra-arterial cisplatin and iv sodium thiosulfate, its antidote, in rat bladder tumor. Cancer Treat Rep 67: 567
Sato H, Hoshi M, Wakui A (1986) Clinical study on angiotensin-induced hypertension chemotherapy (IHC). Jpn J Cancer Chemother 13: 1439
Suzuki M, Hori K, Abe I, Saito S, Sato H (1981) A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with antiotensin II. J Natl Cancer Inst 67: 663
Takematsu H, Tomita Y, Kato T (1985) Angiotensin-induced hypertension and chemotherapy for multiple lesions of malignant melanoma. Br J Dermatol 113: 463
Taniguchi S, Baba T (1982) “Two-route chemotherapy” using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats. Gann 73: 475
Uozumi J, Sagiyama K, Aoki I, Iwamoto Y, Baba T (1983) Effectiveness of “two-route chemotherapy” using cisplatin and its antidote, sodium thiosulfate, on the lifespan of rats bearing metastatic liver tumors. Cancer Treat Rep 67: 1067
Uozumi J, Ishizawa M, Iwamoto Y, Baba T (1984) Sodium thiosulfate inhibits cis-diamminedichloroplatinum(II) activity. Cancer Chemother Pharmacol 13: 82
Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM (1979) Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63: 1527
Wolpert-DeFilippes MK (1979) Antitumor activity of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63:1453
Yano T, Kobayashi H, Inoue H, Uchiyama N, Onohara S, Sonoda T, Shinohara S (1985) Two-channel bronchial artery infusion of cisplatin for treatment of primary lung cancer. Nippon Acta Radiol 45: 486
Young RC, Von Hoff DD, Gormley P, Makuch R, Cassidy J, Howser D, Bull JM (1979) cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Cancer Treat Rep 63: 1539
Author information
Authors and Affiliations
Additional information
Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan
Rights and permissions
About this article
Cite this article
Kobayashi, H., Hasuda, K., Aoki, K. et al. “Two-route chemotherapy” using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats. Cancer Chemother. Pharmacol. 24, 141–147 (1989). https://doi.org/10.1007/BF00300233
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00300233